Prehypertension: a Warning Sign of Future Cardiovascular Risk

Overview

Journal Int J Prev Med

Date 2014 May 3

PMID 24791190

Citations 8

Authors

Farahnak Assadi

Affiliations

Soon will be listed here.

Abstract

Since the report from the national high blood pressure (BP) education program working group on BP in children and adolescents and the introduction of a new description called prehypertension many data have been provided on its rate of progression to hypertension, its prevalence and association with other cardiovascular (CV) risk factors and its therapy. Making a diagnosis of prehypertension in a child or adolescent identifies an individual at increased risk for early-onset CV disease who requires specific treatment. Thus, routine BP measurement is highly recommended at every health-care encounter beginning at 3 years of age. This review will present updated data on prehypertension in children and adolescents to increase awareness of health-care providers to the seriousness of this condition. Optimal BP measurement techniques as well as the evaluation and management of prehypertension will be discussed and preventive strategies to reduce the CV risk will be presented.

Citing Articles

Office blood pressure versus ambulatory blood pressure measurement in childhood obesity.

van der Heijden L, Groothoff J, Feskens E, Janse A BMC Pediatr. 2023; 23(1):205.

PMID: 37120521 PMC: 10148489. DOI: 10.1186/s12887-023-04010-4.

Development and Validation of a Risk Score Screening Tool to Identify People at Risk for Hypertension in Shanghai, China.

Jiang Q, Gong D, Li H, Zhang D, Hu S, Xia Q Risk Manag Healthc Policy. 2022; 15:553-562.

PMID: 35386277 PMC: 8977866. DOI: 10.2147/RMHP.S354057.

Prevalence and associated risk factors of hypertension and pre-hypertension among the adult population: findings from the Dubai Household Survey, 2019.

Mamdouh H, Alnakhi W, Hussain H, Ibrahim G, Hussein A, Mahmoud I BMC Cardiovasc Disord. 2022; 22(1):18.

PMID: 35090385 PMC: 8796637. DOI: 10.1186/s12872-022-02457-4.

Prognostic Model of Prehypertension Risk Based on Molecular Markers.

Sherstnev V, Gruden M, Kuznetsova A, Senko O Bull Exp Biol Med. 2021; 170(5):689-692.

PMID: 33788117 DOI: 10.1007/s10517-021-05134-2.

Effects of Lactotripeptide Supplementation on Tele-Monitored Home Blood Pressure and on Vascular and Renal Function in Prehypertension　- Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study.

Tomiyama H, Fujii M, Shiina K, Ueda S, Iwasaki Y, Matsumoto C Circ Rep. 2021; 1(10):438-444.

PMID: 33693081 PMC: 7897546. DOI: 10.1253/circrep.CR-19-0061.

References

. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

Flynn J, Falkner B . Obesity hypertension in adolescents: epidemiology, evaluation, and management. J Clin Hypertens (Greenwich). 2011; 13(5):323-31. PMC: 8108776. DOI: 10.1111/j.1751-7176.2011.00452.x. View

Mazzali M, Hughes J, Kim Y, Jefferson J, Kang D, Gordon K . Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001; 38(5):1101-6. DOI: 10.1161/hy1101.092839. View

Hansen M, Gunn P, Kaelber D . Underdiagnosis of hypertension in children and adolescents. JAMA. 2007; 298(8):874-9. DOI: 10.1001/jama.298.8.874. View

Assadi F . Strategies to reduce the incidence of chronic kidney disease in children: time for action. J Nephrol. 2012; 26(1):41-7. DOI: 10.5301/jn.5000157. View

Sacks F, Svetkey L, Vollmer W, Appel L, Bray G, Harsha D . Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001; 344(1):3-10. DOI: 10.1056/NEJM200101043440101. View

Sorof J, Daniels S . Obesity hypertension in children: a problem of epidemic proportions. Hypertension. 2002; 40(4):441-7. DOI: 10.1161/01.hyp.0000032940.33466.12. View

Toprak A, Wang H, Chen W, Paul T, Ruan L, Srinivasan S . Prehypertension and black-white contrasts in cardiovascular risk in young adults: Bogalusa Heart Study. J Hypertens. 2009; 27(2):243-50. DOI: 10.1097/hjh.0b013e32831aeee3. View

Assadi F . The growing epidemic of hypertension among children and adolescents: a challenging road ahead. Pediatr Cardiol. 2012; 33(7):1013-20. DOI: 10.1007/s00246-012-0333-5. View

10.

Vasan R, Larson M, Leip E, Evans J, ODonnell C, Kannel W . Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2002; 345(18):1291-7. DOI: 10.1056/NEJMoa003417. View

11.

Player M, King D, Mainous 3rd A, Geesey M . Psychosocial factors and progression from prehypertension to hypertension or coronary heart disease. Ann Fam Med. 2007; 5(5):403-11. PMC: 2000300. DOI: 10.1370/afm.738. View

12.

Muntner P, He J, Cutler J, Wildman R, Whelton P . Trends in blood pressure among children and adolescents. JAMA. 2004; 291(17):2107-13. DOI: 10.1001/jama.291.17.2107. View

13.

Assadi F . Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol. 2007; 28(1):27-33. DOI: 10.1007/s00246-006-1390-4. View

14.

Appel L, Champagne C, Harsha D, Cooper L, Obarzanek E, Elmer P . Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003; 289(16):2083-93. DOI: 10.1001/jama.289.16.2083. View

15.

Redwine K, Daniels S . Prehypertension in adolescents: risk and progression. J Clin Hypertens (Greenwich). 2012; 14(6):360-4. PMC: 3999592. DOI: 10.1111/j.1751-7176.2012.00663.x. View

16.

Falkner B, Gidding S, Portman R, Rosner B . Blood pressure variability and classification of prehypertension and hypertension in adolescence. Pediatrics. 2008; 122(2):238-42. DOI: 10.1542/peds.2007-2776. View

17.

. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(2 Suppl 4th Report):555-76. View

18.

Mazzali M, Kanellis J, Han L, Feng L, Chen Q, Kang D . Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol. 2002; 282(6):F991-7. DOI: 10.1152/ajprenal.00283.2001. View

19.

Feig D, Kang D, Johnson R . Uric acid and cardiovascular risk. N Engl J Med. 2008; 359(17):1811-21. PMC: 2684330. DOI: 10.1056/NEJMra0800885. View

20.

Assadi F . Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension. J Nephrol. 2014; 27(1):51-6. DOI: 10.1007/s40620-013-0009-0. View